Connection

MANDEEP BAJAJ to Fatty Liver

This is a "connection" page, showing publications MANDEEP BAJAJ has written about Fatty Liver.
Connection Strength

0.771
  1. Potential of incretin-based therapies for non-alcoholic fatty liver disease. J Diabetes Complications. 2013 Jul-Aug; 27(4):401-6.
    View in: PubMed
    Score: 0.376
  2. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia. 2011 Dec; 54(12):3093-100.
    View in: PubMed
    Score: 0.343
  3. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.